Nanexa Q4 2022 - A Stronger Case
2023-02-17 11:50:00
Redeye return with a research update following the Q4 report and recent progress in the company. We adjust our valuation to reflect the current pipeline and will likely return further in H1 with a more thorough review.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/